Educating and Informing Patients Receiving Psychopharmacological Medications: Are Family Physicians in Pakistan up to the Task? by Ganatra, Hammad Ashraf et al.
Educating and Informing Patients Receiving
Psychopharmacological Medications: Are Family
Physicians in Pakistan up to the Task?
Hammad Ashraf Ganatra
1*, Hadi Bhurgri
1, Roomasa Channa
1, Fauzia Ahmad Bawany
1, Syed Nabeel
Zafar
1, Rafia Ishfaq Chaudhry
1, Syeda Hina Batool
1, Abdul Basit
1, Mehmood Asghar
1, Sarah Saleem
2,
Haider Naqvi
3
1Medical College, The Aga Khan University, Karachi, Pakistan, 2Department of Community Health Sciences, The Aga Khan University, Karachi, Pakistan, 3Department of
Psychiatry, The Aga Khan University, Karachi, Pakistan
Abstract
Introduction: Studies have shown a high prevalence of psychiatric illnesses among patients in primary health care settings.
Family physicians have a fundamental role in managing psychiatric illness with psychopharmacological medications.
Providing information about the disease, its management and the potential adverse effects of the medications is an
important part of the management of mental illnesses. Our objective was to determine if patients who were prescribed
psychopharmacological drugs by family physicians at a community health center in Karachi, Pakistan were provided
adequate education about their disease and its management.
Methods: A cross-sectional study was conducted at the Community Health Centre (CHC), Aga Khan University Hospital
Karachi, Pakistan. Details about the prescriptions and patient education were acquired from the patients after their
consultations.
Results: A total of 354 adult patients were interviewed during 3 days. Among them, 73 (20.6%) were prescribed
psychopharmacological medications. Among patients receiving psychopharmacological medicines, 37 (50.7%) did not know
their diagnosis; 50 (68.5%) were unaware of the disease process; 52 (71.2%) were unaware of alternative treatments; 63
(86.3%) were not cautioned about the potential adverse effects of the drugs; 24 (32.9%) were unaware of the duration of
treatment and in 60 (82.2%) of the participants an appropriate referral had not been discussed. For all aspects of education,
patients prescribed psychopharmacological medications knew less as compared to those patients that were prescribed
other medications.
Discussion: The practice of imparting information to patients who receive psychopharmacological medications seems to be
inadequate in Pakistan. We have hypothesized about the possible reasons for our findings, and identified a need for further
research to determine the cause for such findings and to address them accordingly. At the same time there is a need to
educate family physicians in Pakistan about the special importance of providing adequate information to such patients.
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Introduction
Common psychiatric illnesses like anxiety and depressive
disorders are highly prevalent all over the world. Estimates from
2001 ranks depression among the top ten causes of disability
worldwide[1]. Depression is projected to become the second
leading cause of disability in the world while the foremost cause in
the underdeveloped countries by the year 2020[2]. The mounting
burden of such disorders presents more of a challenge for the
developing world, where only a minor percentage of the gross
domestic product is allocated to health care.
Theroleoffamilyphysiciansisfundamentalinmanagingcommon
psychiatricillnesses.Several studieshave shown that the prevalence of
psychiatric illnesses among patients visiting primary health care
p r o v i d e r si sh i g h .T h ep r e v a l e n c eo fp sychiatric morbidity in Pakistan
ranged from 10% to 25% for men and 25% to 57% for women in an
analysis of 20 community based studies[3]. Sabooh et al reported the
prevalence of common psychiatric illnesses in primary care settings to
vary from 17% to 30%[4].
The prescription of psychopharmacological medications plays a
major role in the management of common mental disorders. In
Pakistan, thereare currently only 350 psychiatrists for a population of
150million[5]. The high prevalence ofpsychiatricillnessesinprimary
care clinics often leads to hasty diagnostic and therapeutic decisions.
Evaluation and diagnosis of common mental disorders like anxiety
and depression involves a challenge to the clinical ability, knowledge
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4620and experience of the family physicians. Due to the dearth of
psychiatrists, most patients with psychiatric illnesses are being
managed by family physicians[6]. Therefore it is imperative to know
how they fare when it comes to prescribing psychopharmacological
medications and if adequate information about the disease is being
provided. Providing adequate information about the disease and its
managementisofspecialimportanceinthetreatmentofpatientswith
mental illnesses. There is evidence that adequate information helps
improve patient cooperation, medication compliance, tolerance to
unwanted effects and the efficacy of medications and reduce the rate
of unwanted drug effects[7].
The purpose of our study was to determine if patients who were
prescribed psychopharmacological drugs by family physicians at a
reputable community health center in Karachi, Pakistan receive
adequate education about their disease and its management.
Methods
We carried out a cross-sectional study among patients attending
the familymedicine clinics at the Community Health Centre(CHC)
at the Aga Khan University Hospital (AKUH), Karachi. Karachi is
the largest city of Pakistan with an estimated population of 18
million[8]. AKUH is a privately managed tertiary care, university
hospital, located in the centre of the city. The CHC provides
primary health care services within AKUH premises and it serves
patients from all socio-economic backgrounds. It comprises of 10
clinics which are conducted by trained family physicians that are
certified by local or foreign examination boards. According to
current estimates, the CHC has an average daily turnover of 250
patients. This number includes adults and children attending family
medicine clinics, as well as specialty clinics and those coming in for
brief surgical and medical procedures.
Sampling Method
We interviewed all adult patients attending the family medicine
clinics at the CHC over a period of 3 days in January 2008. They
were consecutively approached for an interview after their
consultation was over and they had received their prescriptions.
Patients attending specialty clinics, or those who were less than 18
years of age were excluded from the study.
Questionnaire and Data Collection
We designed a structured interview based questionnaire which
comprised of 3 parts. The first dealt with the socio-demographic
profile of the participants (e.g. age, sex, education, marital status).
The second part documented the drugs prescribed during the
consultation. The third and final part assessed whether the patients
had been provided adequate information about their diagnosis and
its prognosis and about the drugs that they had been prescribed
(e.g. adverse effects, duration of treatment)
We originally designed the questionnaire in English and then
translated it into Urdu. To ensure that the original wordings were
preserved, it was then back translated into English by three
different non-medical individuals not related to the study. We then
pre-tested this final Urdu questionnaire on 36 subjects to identify
any shortcomings of the questionnaire. Some minor problems
were identified and we made the appropriate modifications. Data
from the pre-test was not included in the final analysis.
The interviews were conducted by a group of senior medical
students who were briefed about the study protocol and trained in
survey techniques. The interviewers assembled at the CHC, before
the start of the clinics. All patients were approached after their
consultation was over, and they had received their prescriptions.
After taking informed consent, they were interviewed, and their
responses were recorded on the questionnaire. Throughout the
period of data collection, the family physicians were unaware of
the study going on outside their doors. This was intentional and
important for the study design.
During the interview, all participants were asked to show their
prescriptions which were then noted down in the questionnaire.
Before data entry, all the trade names were converted into generic
names using PharmaGuide[9], and all psychopharmacological
medications were coded into different classes according to their
respective modes of action like anti-depressants, anxiolytics, etc.
and their subtypes.
Statistical Analysis
We performed data entry on Epi Data version 3.1 and statistical
analyses were done using Statistical Package for Social Sciences
14.0 (SPSS, Inc., Chicago, IL, USA). Descriptive statistics
including means and standard deviation (SD) were calculated for
continuous variables, while proportions were calculated and
tabulated for categorical variables. Demographic details of patients
receiving psychopharmacological drugs or other medications were
tabulated. The Pearson chi-square test and Independent T-test
were used for categorical and continuous variables respectively, to
assess for significant differences between the two patient groups.
We used the Fisher’s exact test to assess if the patient education
differed between those receiving psychopharmacological drugs
and those receiving other kinds of prescriptions.
Ethical Considerations
The study was approved by the Ethical Review Committee of
the Department of Community Health Sciences at AKUH. We
also obtained permission from the Department of Family
Medicine.
An informed consent form in Urdu was also attached with the
questionnaire which informed all potential participants about the
benefits and harms of the study. The interviewers read out the
consent form to participants who were unable to read it. Written
informed consent was taken from all participants before proceeding
with the interview. The questionnaire was anonymous and
guaranteed the confidentiality of the study participants as it did not
document any information that could link individuals to the study.
Results
We approached a total of 368 patients aged 18 and above over a
period of 3 days, out of which 354 participated in our study with a
response rate of 96.2%. Of the total participants, 251 (70.9%) were
married, and 220 (62.1%) were unemployed. There were a total of
230 females which comprised 65.0% of the participants. The
mean age of the participants was 38.8 years (SD 15.3). Of the
participants, 130 (36.8%) were illiterate or had received primary
education only. 54.5% had come in for a follow-up visit and
71.5% were financing their own healthcare. All patients who were
interviewed had received a prescription from their family
physician, either in the form of therapeutic or symptomatic
medication. Prescription of psychopharmacological medications
was found among 73 (20.6%) of the participants. Table 1 presents
the differences in demographic profiles of the patients receiving
psychotropic medications versus those receiving other medica-
tions. Among the patients prescribed psychopharmacological
medications, 35 (47.9%) received Selective Serotonin Reuptake
Inhibitors (SSRI), 23 (31.5%) received Tricyclic Antidepressants
(TCA) and 15 (20.5%) received Benzodiazepines (BDZ).
For all aspects of education, patients prescribed psychophar-
macological medications knew less as compared to those patients
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among the patients receiving psychopharmacological medications,
50.7% did not know their diagnosis compared to 27.9% of patients
with other medications (p-value,0.001); 68.5% (versus 48.4%) of
the participants were not explained the disease process in layman
terms (p-value=0.002); 71.2% (versus 56.2%) of the participants
were not counseled about alternative treatments (p-value=0.020);
86.3% (versus 77.7%) of the participants were not explained the
adverse effects of the drugs (p-value=0.107); 32.9% (versus 23.3%)
were not aware of the duration of treatment (p-value=0.093) and
with 82.2% (versus 74.9%) of the participants an appropriate
referral had not been discussed (p-value=0.192).
Discussion
Questions have been raised about the relevance of psychophar-
macological prescriptions in primary health care practice[10].
These drugs can have serious side effects and some of them,
especially the benzodiazepines have an addictive potential.
Therefore, their prescription and use should be monitored by a
healthcare professional. Also, the treatment of mental disorders
entails more than just prescription of medicines; it also requires the
doctor to develop a strong bond with the patient, and to counsel
the patients regarding alternative treatment options. In this
context, several of our findings were distressing.
Almost 51% of the patients with psychopharmacological
medications did not know their diagnosis. Several factors could
be responsible for this. Most of the psychopharmacological
medicines in our study were antidepressants and it is possible that
doctors were hesitant to tell patients that they were suffering from
depression. Further, patients may have refused the diagnosis due
to the social stigma associated with psychiatric diseases, or they
may have been unable to understand the diagnosis due to
cognitive disability associated with psychiatric illnesses. At the
same time it can also be argued that the doctors were unable to
effectively explain the diagnosis to their patients because they
themselves were unclear about it.
With almost 71% of the patients no alternative treatment
options were discussed. This issue must be addressed because
addition of non-pharmacological treatment options can be helpful
Table 1. Demographic profile of the patients receiving psychopharmacological medications and patients receiving other
medications (n=354).
Variable
Patients receiving
psychopharmacological drugs
(n=73) Number (%)
Patients receiving other drugs
(n=281) Number (%) P-Value*
Gender
Male 13 (17.8) 111 (39.5) 0.001
Female 60 (82.2) 170 (60.5)
Age
Age Range (Min–Max) in Years 18–79 18–85 0.005
1
Mean Age in Years6SD 43.3615.4 37.6615.0
Marital Status
Unmarried 10 (13.7) 85 (30.2) 0.011
Married 61 (83.6) 190 (67.6)
Widowed 2 (2.7) 2 (0.7)
Divorced 0 (0) 4 (1.4)
Highest level of education
Illiterate 21 (28.8) 50 (17.8) ,0.001
Primary 14 (19.2) 45 (16.0)
Secondary 21 (28.8) 38 (13.5)
Intermediate 5 (6.8) 32 (11.4)
College Graduation 10 (13.7) 100 (35.6)
Post graduation 2 (2.7) 16 (5.7)
Employment status
Unemployed (including housewives and job seeking
individuals)
53 (72.6) 167 (59.4) 0.096
Employed 17 (23.3) 103 (36.7)
Retired 3 (4.1) 11 (3.9)
Total monthly household income (in Rupees)
,10,000 27 (37.0) 88 (31.3) 0.519
10,000–45,000 35 (47.9) 140 (49.8)
45,000–100,000 8 (11.0) 46 (16.4)
.100,000 3 (4.1) 7 (2.5)
*Pearson Chi-square was used to calculate p-values.
1Independent Samples T-Test was used to calculate p-value.
doi:10.1371/journal.pone.0004620.t001
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anxiety and depression, and in milder cases these may be the only
forms of treatment required[11,12]. This finding can also be
interpreted as a sign of over dependence on medications on the
part of family physicians when it comes to managing such
disorders, given that often there are several pharmacological and
non-pharmacological treatment options.
Adverse effects of the drugs had not been explained to almost
86% of the patients being prescribed psychopharmacological
medications. SSRIs have fewer side effects, but TCAs and
benzodiazepines have significant ill-effects which should be
discussed with the patients before initiating therapy. In general,
most patients attending primary care services want to know the
adverse effects of the treatment being prescribed to them[13].
Although, most patients knew about the duration of treatment, a
third did not. This can prove hazardous as prolonged treatment
with benzodiazepines can lead to dependence[14,15], while
stopping antidepressants before time is likely to lead to relapse[16].
With almost 82% of the patients no referral plan was discussed.
This complements the findings of a previous study which showed
that only 3% of the patients in a psychiatry clinic had been
referred by primary care physicians[6]. The low rate of referral
makes it all the more important for the physicians at first level of
care to be well versed in the management of mental illness. In a
developing country like Pakistan mental illnesses make up a
significant proportion of the total disease burden and trained
psychiatrists are few. Consequently, correct identification and
effective management of common psychiatric disorders by family
physicians becomes essential[17].
The most common psychopharmacological medicines pre-
scribed were antidepressants with relatively fewer prescriptions
of benzodiazepines. This pattern differs from other studies which
show benzodiazepines rather than antidepressants as being the
most commonly prescribed psychopharmacological medi-
cine[18,19]. This is an encouraging finding as benzodiazepines
have a high potential for addiction and should be used judiciously.
The doctors in our study were trained, local or international board
certified family physicians who had been exposed to psychiatric
patients during their training and were therefore able to make a
more informed decision about benzodiazepine prescription. This
may explain the low prescription rate of benzodiazepines. It may
be worthwhile to carry out a similar study among primary care
physicians without specialized training to know how they fare
when prescribing psychopharmacological medications. Postgrad-
uate training of family physicians in treating common psychiatric
disorders has been suggested to protect patients against unneces-
sary prescription of psychopharmacological medications [20].
On the whole, all aspects of providing information to patients
receiving psychopharmacological prescriptions were inadequate.
This is a cause of concern as the doctors involved in our study
were trained family physicians, whereas most primary care doctors
in Pakistan receive no such training. A recent study showed that
although there are very few formal training programs for family
medicine in Pakistan, they are of international standards.
However, very few doctors go through these training programs
and most of them venture into family practice right after their
house jobs without any continued training[21]. There is no reason
to believe that their performance would be any better, in fact it is
our belief that it would be worse. Given that the quality of mental
health care provided by untrained family physicians and self-
proclaimed medical workers (‘‘quacks’’ and ‘‘hakims’’) in Pakistan
is not known, there is a need to assess how less specialized health
care providers fare when managing patients with suspected
psychiatric illnesses.
At the same time, measures are needed to improve the
performance of existing trained and untrained family physicians,
and to educate them about the importance of providing
information to patients receiving psychopharmacological medica-
tions. This can be done by enrolling them in Continuous Medical
Education seminars or special courses and workshops throughout
the country Such interventions have been suggested and proven
beneficial in other countries too[22,23].
However, additional factors might be responsible for the
inadequate practice of patient education seen in our sample. As
shown in Table 1, the study participants who received psycho-
pharmacological drugs differed from other patients with regards to
gender, mean age, marital status and educational level. There
were more illiterate or less educated individuals, and less college
graduates and postgraduates. This suggests that these patients
were adequately educated about their disease by the physicians but
had a poor retention or comprehension of the counseling session
due to their lower educational status. Similarly, the group of
patients receiving psychopharmacological drugs had a higher
proportion of females (82.2%) as compared to those with other
medications (60.5%). Females in Pakistan generally have a lower
Table 2. Teaching of patients prescribed
psychopharmacological medications vs. those who were
prescribed other medications (n=354).
Variables
Patients receiving
psychopharmacological
drugs (n=73) Number (%)
Patients receiving
other drugs* (n=281)
Number (%)
Did the patient know his/her diagnosis?
Yes 36 (49.3) 199 (72.1)
No 37 (50.7) 77 (27.9)
(p value,0.001)
Did the patient know about the disease process?
Yes 23 (31.5) 142 (51.6)
No 50 (68.5) 133 (48.4)
(p value=0.002)
Were alternate treatment options discussed?
Yes 21 (28.8) 120 (43.8)
No 52 (71.2) 154 (56.2)
(p value=0.020)
Were adverse effects explained?
Yes 10 (13.7) 61 (22.3)
No 63 (86.3) 213 (77.7)
(p value=0.107)
Did the patient know the approximate duration of treatment?
Yes 49 (67.1) 211 (76.7)
No 24 (32.9) 64 (23.3)
(p value=0.093)
Was an appropriate referral discussed?
Yes 13 (17.8) 69 (25.1)
No 60 (82.2) 206 (74.9)
(p value=0.192)
Fisher’s Exact Test was used to calculate the p-values.
*Numbers in the column ‘‘Other drugs’’ do not add up due to non-responders
among this group who did not divulge particular information about their
consultation.
doi:10.1371/journal.pone.0004620.t002
Family Physicians & Counseling
PLoS ONE | www.plosone.org 4 February 2009 | Volume 4 | Issue 2 | e4620educational status, and the lower quality of counseling reported by
females might be a reflection of their poor understanding and
comprehension secondary to lower education.
The patients with psychopharmacological medication were also
older than those receiving other medications (43.3 years vs 37.6
years, p-value 0.005). A greater number of elderly patients in one
group might have had cognitive defects leading to poor
comprehension of the information provided by the physician.
Also, the family physicians might have had problems in
communicating with the elderly patients.
It is also possible that a quantity driven and profit oriented clinic
setting makes it difficult to adequately counsel patients due to
practical constraints like lack of time. In a previous study it was
speculated that market influences were a possible reason for poor
prescribing practices, as physicians in Pakistan participate in a
market where consultations including patient education and
medications are bought and sold[24]. Such constraints might be
overcome to some extent if standardized patient leaflets were used
to facilitate communication. Further, it is possible that only
‘‘difficult’’ or chronic patients received psychopharmacological
medications due to feelings of helplessness on part of the physician.
This might have led to a poorer quality of patient education in
these cases as a clear plan for the treatment was not present. It has
also been argued that the poor level of mental health literacy
among patients could be a reason for the inadequate management
of psychiatric illnesses in the country[25]. It was not our objective
to pin-point the specific reasons behind this inadequate counseling
but to merely determine if it is an issue of concern or not.
There were certain limitations to our study. Our data was
collected from 2 sources i.e. the patients’ prescriptions and the
questionnaire based interviews. As regards the interview, some
participants had been diagnosed with common mental disorders
like anxiety and depression, or were taking psychopharmacological
medications. This might have introduced an element of informa-
tion bias in our study as both these factors are known to cause
cognitive impairment. Also, our study was a cross-sectional survey
and we recruited patients consecutively. It is an inherent limitation
of the study that we cannot comment on the representativeness of
the patients recruited during the three days. While all prescribing
CHC doctors were trained and accredited family physicians, this
setting cannot be generalized to the general practitioners
throughout the country which comprise mostly of untrained
doctors. The fact that there were multiple interviewers could also
have led to an element of interviewer bias. However, we strived to
eliminate this by designing a standard questionnaire and all
interviewers read out the same standard set of questions during the
interview.
Conclusion
Pakistan is a developing country with limited healthcare
resources and very few mental health professionals. In such a
setting, family physicians have a responsibility of effectively
managing mental illnesses; effective education of the patients
about their disease and treatment options is a vital component of
disease management. Our study gives an insight into how family
physicians in Pakistan prescribe psychopharmacological drugs and
shows that, when it comes to imparting information and
education, there are significant communication gaps between
physicians and patients. It shows that a significant proportion of
patients attending primary care services receive psychopharma-
cological medication without adequate education about their
disease and its management. We have hypothesized about factors
that may be responsible for this including physician-related factors
like poor training, time constraints and profit motivated practice,
and patient-related factors like low education, older age and poor
level of mental health literacy among patients. However, the
definite reasons for the lack of proper patient education should be
explored by further research. At the same time there is a need to
educate family physicians in this regard and to develop strategies
to improve their communication skills.
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